	Improved Pharma announced on May 5, 2020 that it has expanded its microscopy services with the addition of infrared microspectroscopy and hot stage optical microscopy.

	According to a company press release, the new additions include:

		Nikon, SMZ800 with Schott fiber optic illumination and HD digital imaging

		Olympus BX51TRF, which features transmitted and reflected brightfield/darkfield illumination (including fluorescence microscopy capabilities) with HD digital imaging

		Olympus BH2-BHS reflected polarized light microscopy equipped with differential interference contrast and HD digital imaging

		Linkam LTS420 hot stage with T95 Temperature Controller and LNP (liquid nitrogen pump)

	The new instrumentation will join the company’s current offerings of stereomicroscopy and polarized light microscopy.

	"The amount of information that can be obtained from even a single particle can solve many complex problems often encountered in pharmaceutical development,” said Pamela Smith, chief operating officer, Improved Pharma, in the press release. “Contaminant identification, detection of polymorphic changes, and full thermal characterization are just some of the new capabilities we can now offer in-house.”

COVID-19 Update

Pharmaceutical Technology\'s In the Lab eNewsletter-06-03-2020

The company has expanded its microscopy services with the addition of infrared microspectroscopy and hot stage optical microscopy. 